Brief: Tivic Health Partners With The Feinstein Institutes To Advance Its Patent-Pending, Non-Invasive Cervical Vagus Nerve Stimulation Begins Optimization Of Ncvns For Use In Clinical Indications
22/05/2024 14:06
May 22 (Reuters) - Tivic Health Systems Inc TIVC.O :
* TIVIC HEALTH PARTNERS WITH THE FEINSTEIN INSTITUTES TO
ADVANCE
ITS PATENT-PENDING, NON-INVASIVE CERVICAL VAGUS NERVE
STIMULATION; BEGINS OPTIMIZATION OF NCVNS FOR USE IN CLINICAL
INDICATIONS
Source text for Eikon: ID:nBw3b9Jq0a
Further company coverage: TIVC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital